MannKind Corp. (MNKD)

[XenaLives]

Oral or Sub-Lingual delivery of drugs and supplements is a valid pathway. With the obstruction that the company has seen in the diabetes market, it may be a valid business plan to develop an alternative business model until the U.S. healthcare system becomes more evidence based and less money minded.

B-12 is a great example of a very important supplement that could be profitably marketed with a better delivery system.